A business in context
KYMR research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 10658.0 | 108.28 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 7833.0 | 109.75 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 157.0 | 111.2 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 1199.0 | 110.67 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 7602.0 | 110.67 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 907.0 | 111.2 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 1688.0 | 108.28 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 1239.0 | 109.75 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 5471.0 | 105.78 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 14613.0 | 106.63 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 19093.0 | 107.76 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 848.0 | 105.78 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 2318.0 | 106.63 |
| 2026-06-29 | Booth Bruce | S · Sale | Common Stock | 3024.0 | 107.76 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 28296.0 | 107.57 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 231007.0 | 108.14 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 32624.0 | 109.79 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 11277.0 | 110.49 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 10366.0 | 111.51 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 555.0 | 112.49 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 14913.0 | 113.97 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 27951.0 | 114.94 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 6821.0 | 115.69 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 12181.0 | 117.09 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 22046.0 | 117.85 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 12390.0 | 118.66 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 3958.0 | 107.57 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 32402.0 | 108.14 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 4562.0 | 109.79 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 1579.0 | 110.49 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 1442.0 | 111.51 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 78.0 | 112.49 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 2083.0 | 113.97 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 3896.0 | 114.94 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 952.0 | 115.69 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 1701.0 | 117.09 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 3069.0 | 117.85 |
| 2026-06-26 | Booth Bruce | S · Sale | Common Stock | 1729.0 | 118.66 |
| 2026-06-26 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | S · Sale | Common Stock, $0.0001 par value | 837914.0 | 106.5 |
| 2026-06-26 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | S · Sale | Common Stock, $0.0001 par value | 51858.0 | 106.5 |
| 2026-06-26 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | S · Sale | Common Stock, $0.0001 par value | 113289.0 | 106.5 |
| 2026-06-26 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | S · Sale | Common Stock, $0.0001 par value | 627597.0 | 106.5 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 305.0 | 128.69 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 46.0 | 129.61 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 37179.0 | 119.71 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 112299.0 | 120.66 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 40774.0 | 121.38 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 4977.0 | 122.67 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 10860.0 | 123.62 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 11711.0 | 124.61 |
Identity & relationships
SEC issuer · 0001815442Kymera Therapeutics, Inc.
Search names and former names
View Wikidata identity and references ↗
- Kymera Therapeutics · alias · wikidata
- Kymera Therapeutics, Inc. · former SEC name · 2020-06-22 to 2026-09-04
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $47.07M | $50.11M |
| 2023-12-31 | $78.59M | $86.12M |
| 2022-12-31 | $46.83M | $53.42M |
| 2021-12-31 | $72.83M | $89.74M |
| 2020-12-31 | $34.03M | $43.91M |
| 2019-12-31 | $2.93M | $3.83M |